Position in NTLA
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$3,076
+$919 QoQ
Shares Held
240
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Asset Dedication, LLC holds $180,231 across 12 Biotechnology names. NTLA ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
237 | $105,829 | |
| 2 | MRNA |
Moderna, Inc.
|
843 | $42,824 | |
| 3 | LGVN |
Longeveron Inc.
|
10,500 | $10,920 | |
| 4 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
1,000 | $6,130 | |
| 5 | BNTX |
BioNTech SE
|
37 | $3,288 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
This page
|
240 | $3,076 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
184 | $1,788 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5 | $1,654 |
All Filings in NTLA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,076 | 240 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $2,157 | 240 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,144 | 240 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $2,251 | 240 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $1,706 | 240 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,798 | 240 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,932 | 240 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $5,371 | 240 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $6,602 | 240 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $7,317 | 240 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||